Filing Details

Accession Number:
0001562180-21-004152
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-09 16:26:29
Reporting Period:
2021-06-07
Accepted Time:
2021-06-09 16:26:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1379970 C Steven Gilman C/o Akebia Therapeutics, Inc.
245 First St.
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-06-07 4,567 $3.32 47,997 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020.
  2. This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price.